Does convalescent serum treatment lower mortality in SARS-CoV-2-infected individuals?
Researchers evaluated the impact of convalescent serum therapy on all-cause mortality among COVID-19 patients.
Source: news-medical.net
Page 20 - Collaborative Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Collaborative Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Collaborative Group Today - Breaking & Trending Today
COPD Prevalence Increases With Age Among Young Patients
Researchers found young patients with chronic obstructive pulmonary disease (COPD) have a higher risk of all-cause mortality than those without COPD.
Source: ajmc.com
TAGRISSO® achieved unprecedented survival in early-stage EGFR-mutated lung cancer, with 88% of patients alive at five years in ADAURA Phase III trial
Treatment with adjuvant TAGRISSO reduced the risk of death by more than half ... | June 4, 2023
Source: marketscreener.com
AstraZeneca: TAGRISSO achieved unprecedented survival in early-stage EGFR-mutated lung cancer, with 88% of patients alive at five years in ADAURA Phase III trial
Treatment with adjuvant TAGRISSO reduced the risk of death by more than half Positive results from the ADAURA Phase III trial showed AstraZeneca's TAGRISSO (osimertinib) demonstrated a statistically
Source: finanznachrichten.de
HRS23 Announces Late-breaking Clinical Trials and Science Sessions
Heart Rhythm 2023, the society's 44th annual meeting, takes place May 19-21, in New Orleans
Source: dicardiology.com